Table:
begin	end	state
1	39	cytoplasmic
40	57	transmembrane
58	78	non-cytoplasmic
79	97	transmembrane
98	107	cytoplasmic
108	134	transmembrane
135	190	non-cytoplasmic
191	214	transmembrane
215	255	cytoplasmic
256	275	transmembrane
276	294	non-cytoplasmic
295	318	transmembrane
319	329	cytoplasmic
330	347	transmembrane
348	352	non-cytoplasmic
353	377	transmembrane
378	388	cytoplasmic
389	412	transmembrane
413	418	non-cytoplasmic
419	439	transmembrane
440	450	cytoplasmic

Input:
>AO353_06195 FitnessBrowser__pseudo3_N2E3:AO353_06195
MIPSQSSHTESARMASGLGVATGGIGDKIRGAMAVGKTRWGMLALVFFATTLNYIDRAAL
GVMQPILAKEMSWTAMDYANINFWFQVGYAVGFVLQGRLIDRIGVKRVFFCAVLLWSLAT
GAHGLATSALGFMVCRFILGLTEAANYPACVKTTRLWFPAGERAVATGIFNAGTNVGAMF
TPMLLPLILHVWGWQAAFLCMSALGGIWLVFWGLKYFNPEDHPSVKQSELDYIQNEAEPE
QARVPFSRILRMRGTWAFALAYSMTAPVFWFYLYWLPPFLNQQYNLGINVTQMGIPLIII
YMTADFGSVGGGILSSFLIGRGVNPIKARLMSMLLFACCIIGVIMAAGSSNLWVAVFAIS
LAIGAHQAWTANIWSLVMDYTPKHMMSTVFGFGGMCAAIGGMFMTQLVGHILTITNNNYT
VLFTMIPAMYFIALIWLYFMAPRKIPNLED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server